THE TAPE
HLF · Drug Wholesalers · $1.7B

Herbalife Ltd.

$16.15▲ +1.19%
Last close
Relative strength
92RS
of 99, against every stock▲ +11 on the month
Powering up
Unconfirmed
+28.1%
six months against the S&P 500
52-week range
−20.8%
from the high
$8.65$20.40
Setup
bull flagfresh breakout
+1.8%
against the pivot at $15.87
No report date on the calendar.
Growth FLATProof SHOWN
Quarter to Sep 30, revenue +6% on a year ago
11/16 O 16.00 H 16.30 L 15.79 Vol 1.8M
Draw
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

The four are not in order. That is a description of where the averages sit, not a view about what happens next.

RS92
vs pivot+1.76%
Tightening—
Dry-up—
Up/down vol0.24
From high21%
fresh breakout5 of 7checks
Previous breakout trailed out ▲ +5.68% in Jan
Powering up
Support and resistance
Support below
$13.06
-19.1% · tested 7× · last 15 sessions ago
Resistance above
None within the last 120 sessions

Prices this stock has turned at three or more times in the last 120 sessions, with how many times. Where buyers and sellers showed up before, not a forecast, an entry or a stop.

The read

The base has run 0.6 weeks and fell 5% from its ceiling at its deepest. The pivot is $15.87, and the stock closed 1.8% above that pivot. Its relative strength rating is 92.

Against its industry
UnconfirmedNone of the patterns above holds.
One month against the S&P 500
+14.1%
Three months against the S&P 500
+35.7%
Six months against the S&P 500
+28.1%

Its industry has too few members to make an index of, so it is read against the S&P 500 and can only be turning, caution or unconfirmed.

Peers
Same industry
Same theme
No themes — common and fine.
Catalyst roadmap

Nothing dated in the next three months that we can ingest automatically.

How it moves on earnings

On average 15.3% either way across its last 8 reports.

Checking your subscription…

Close before the report day to close after it, so it holds whether the company reported before the open or after the close.

The business
Revenue
$5.3B
+6.0% year on year
Operating margin
9.6%
gross 77.6%
Net margin
3.4%
Free cash flow
$337.1M
19.9% of market cap
Price to sales
0.32×
Price to earnings
9.41×

Twelve months to Sep 30, 2026, the four latest quarters in the company’s SEC filings, with the fiscal fourth quarter worked out from the annual report. Revenue growth is the latest quarter against the same quarter a year earlier.

The latest quarter, read by fixed rules · reported Nov 2
Key takeaway
Profitable and cash generating; the question is growth.
Revenue
$1.4B
+1.8% QoQ · +6.0% YoY
Gross margin
77.3%
-0.4 pts QoQ
Net income
$58.8M
Positive
Free cash flow
$132.8M
Cash generating

What the numbers say

  • Revenue +6.0% year over year, +1.8% on the quarter
  • Gross margin 77.3%, -0.4 points on the quarter
  • Good: Profitable: net income $59M, operating margin 10.3%
  • Good: Cash generating: operating cash flow $151M, free cash flow $133M
  • Net debt $1.52B · cash $409M
Revenue by quarter
Free cash flow
Net income
shares +3.2% in a year · net debt $1.5B

The desk’s own read

Flagged as drifting up since the report

Final read
Growth: FLAT · Economic proof: SHOWN
Key question: Can the cash generation hold as growth slows?
The next test is whether the quarter repeats.

From the company’s 10-Q and 10-K filings, by Market Desk’s rules. Every line, the takeaway and the final read are fixed rules on the filed numbers; nothing reads the press release, and none of it enters a screen or a rating. Every recent reporter.

Tracked funds

None of the tracked funds held or sold it in their latest filings.

Flagged by the market sweep
Tightening after a sharp runTape · 2026-11-14
range halved after a +22% thrust, at 15.96
No measurable effect: stocks behave like random ones over the next three sessions (887 cases over 60 nights).
Pulled back while its group leadsTape · 2026-11-13
3 lower closes in a leading group, 50d held, at 15.21
Mixed: stocks have lagged random stocks by 1.0% over three sessions, not consistently enough to call (433 cases over 59 nights). Against their own sector they have lagged by 0.9%.
GappedTape · 2026-11-05
+6.5%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Unusual volumeTape · 2026-11-05
4.1 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.
Closed above its 20- and 50-day on heavy volumeTape · 2026-11-04
above 20d & 50d on 2.2x volume at 14.38
Mixed: stocks have outrun random stocks by 0.2% over three sessions, not consistently enough to call (1,668 cases over 60 nights). Against their own sector they have lagged by 0.7%.
GappedTape · 2026-11-04
+8.3%
After this signal, stocks have lagged random stocks by 0.9% over the next three sessions (18,291 cases over 56 nights). Against their own sector they have lagged by 1.2%.
Moved 5%+ up on earningsTape · 2026-11-04
+8.3% on earnings 2026-11-02
No measurable effect: stocks behave like random ones over the next three sessions (604 cases over 42 nights).
Unusual volumeTape · 2026-11-04
5.7 sigma
After this signal, stocks have lagged random stocks by 0.1% over the next three sessions (6,474 cases over 55 nights). Against their own sector they have lagged by 0.4%.

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means. The track record is the sweep's own, measured against random stocks over the last 90 days.

In the news
Why Herbalife Stock Is Up TodayThe Motley Fool · 2026-11-03Herbalife Ltd (HLF) Misses Q3 Earnings EstimatesZacks Investment Research · 2026-11-02

Headlines link to the publisher. We do not host, summarise or rank them, and a headline appearing here is not a view about the company.

Insiders
Bought on the open market
1
$13,572 total
Sold on the open market
0

Bought: L'Helias Sophie.

Not counted above: 1 filing for awards, option exercises, gifts or shares withheld to pay tax. Those follow a vesting schedule nobody chose the timing of, and counting them as selling is how that number gets misread.

Most recent filings
2026-08-04 Lamberti Frank · Chief Commercial Officerwithheld for tax1,710$21,888
2026-06-04 L'Helias Sophie · Directorbuy1,200$13,572

From SEC Form 4, filed within two business days of the trade. What was filed, not what it means.

The geometry
Level · ceiling$15.87
The pole · over 5 sessions+18.2%
Through to the apex · the lines run parallel, so they never meetn/a
Touches · swing points the lines are drawn through3 up · 3 down
Length0.6 weeks
What lines up

5 of 7 published checks currently line up. This is a count, not a probability — nothing on this site measures how often a setup works.

Relative strength of 80 or better
Above its 50-day line
Above its 200-day line
Averages fully stacked
Within 5% of its pivot
More up-volume than down-volume
Within 15% of its 52-week high

2 checks are not listed because this stock has too little history to judge them — a 200-day average needs 200 sessions. They are left out of the total rather than counted as failures.

What analysts expect
Strong buy1
Buy2
Hold0
Sell0
Strong sell1

These are analysts’ estimates, not ours, and not a projection this site endorses. They are published here because what the sell side expects is itself a fact about the market.

Checking your subscription…

Gamma concentration

No option open interest for this company. Most listed names have no options at all, and we only read chains for names carrying a dated event, so this is a normal reading rather than a fault.

X-ray

The most recent of 3 completed bases.

Checking your subscription…

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. A stock on a screen matches a shape; that is not a prediction. Prices are end-of-day, not live.

What that means, in full
Herbalife Ltd. (HLF) — The Tape